Searching for:
Found 1,000 results
Pages: 1 2 3 ...
: Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol. 17 (9):2639-48 (1999)
: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 107 (3):391-7 (2003)
: Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 105 (3):310-5 (2002)
(search: 0.010 sec. - facets: 1.149 sec.) (?)
Pages: 1 2 3 ...

Refine by YEAR:

show:
[No canvas support]